Abstract
The current standard of care for acute ischemic stroke is intravenous recombinant tissue type plasminogen activator (rt-PA) for eligible patients who present within 3–4.5 h from stroke onset.1 ,2 There...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
